Glenda M. Halliday

Research interests

Publications

• The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy

  Movement Disorders · 2022 · https://doi.org/10.1002/mds.29005

• Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing

  Science Advances · 2022 · https://doi.org/10.1126/sciadv.abm5386

• Parkinson disease-associated cognitive impairment

  Nature Reviews Disease Primers · 2021 · https://doi.org/10.1038/s41572-021-00280-3

• Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

  Nature Genetics · 2021 · https://doi.org/10.1038/s41588-021-00785-3

• Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

  npj Parkinson s Disease · 2021 · https://doi.org/10.1038/s41531-021-00203-9

• Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

  The Lancet Neurology · 2019 · https://doi.org/10.1016/s1474-4422(19)30394-1

• Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report

  Brain · 2019 · https://doi.org/10.1093/brain/awz099

• Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing

  Genome Medicine · 2019 · https://doi.org/10.1186/s13073-019-0667-1

• Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD

  Acta Neuropathologica · 2019 · https://doi.org/10.1007/s00401-019-01962-9

• Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study

  The Lancet Neurology · 2017 · https://doi.org/10.1016/s1474-4422(17)30400-3

• Parkinson disease

  Nature Reviews Disease Primers · 2017 · https://doi.org/10.1038/nrdp.2017.13

• Diagnosis and management of dementia with Lewy bodies

  Neurology · 2017 · https://doi.org/10.1212/wnl.0000000000004058

• Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

  Movement Disorders · 2017 · 10.1002/mds.27115

• Selective neuronal vulnerability in Parkinson disease

  Nature reviews. Neuroscience · 2017 · 10.1038/nrn.2016.178

• MDS research criteria for prodromal Parkinson's disease

  Movement Disorders · 2015 · 10.1002/mds.26431

• MDS clinical diagnostic criteria for Parkinson's disease

  Movement Disorders · 2015 · https://doi.org/10.1002/mds.26424

• Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism

  Proceedings of the National Academy of Sciences · 2015 · 10.1073/pnas.1514475112

• Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

  Acta Neuropathologica · 2015 · https://doi.org/10.1007/s00401-015-1509-x

• Frontotemporal dementia and its subtypes: a genome-wide association study

  The Lancet Neurology · 2014 · https://doi.org/10.1016/s1474-4422(14)70065-1

• TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions

  Acta Neuropathologica · 2014 · https://doi.org/10.1007/s00401-013-1239-x

• A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies

  JAMA Neurology · 2013 · https://doi.org/10.1001/jamaneurol.2013.1925

• Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease

  Brain · 2013 · 10.1093/brain/awt192

• Missing pieces in the Parkinson's disease puzzle

  Nature Medicine · 2010 · 10.1038/nm.2165

• Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

  Nature Genetics · 2010 · 10.1038/ng.536

• FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

  Acta Neuropathologica · 2010 · https://doi.org/10.1007/s00401-010-0698-6

• Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria

  The Lancet Neurology · 2009 · 10.1016/s1474-4422(09)70238-8

• Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

  Acta Neuropathologica · 2009 · 10.1007/s00401-009-0612-2

• The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

  Movement Disorders · 2008 · https://doi.org/10.1002/mds.21956

• Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

  Acta Neuropathologica · 2007 · 10.1007/s00401-007-0237-2

• Diagnosis and management of dementia with Lewy bodies

  Neurology · 2005 · https://doi.org/10.1212/01.wnl.0000187889.17253.b1

• Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr α‐synuclein mutation

  Annals of Neurology · 2001 · 10.1002/ana.67

• Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity

  Brain Research Reviews · 1987 · 10.1016/0165-0173(87)90011-7

Current projects

No projects listed.